Obstetrics & Gynecology, Gynecologic Oncology · Columbia, SC
NPI
1609070143
Since 2007
Specialty
Obstetrics & Gynecology, Gynecologic Oncology
Code 207VX0201X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
166 Stoneridge Dr
Columbia, SC, 29210
Phone (803) 461-3000
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.3M
176,137 services
Medicare patients, 2024
510
Average age 74
Drug cost, 2024
$1.5M
688 prescriptions
Company payments, 2025
$1,811
From 33 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by William M Merritt was code J9267 (injection, paclitaxel, 1 mg), 55,574 times for 51 patients. In total William M Merritt billed 176,137 services in 144 codes, and Medicare paid $2.3M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-08-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9267 Injection, paclitaxel, 1 mg | Office | 55,574 | 51 | $0.08 | $4,392 |
| J0185 Injection, aprepitant, 1 mg | Office | 25,220 | 54 | $1.32 | $33K |
| J1627 Injection, granisetron, extended-release, 0.1 mg | Office | 15,300 | 43 | $4.26 | $65K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 12,800 | 13 | $44.87 | $574K |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 12,035 | 85 | $0.10 | $1,184 |
| J1449 Injection, eflapegrastim-xnst, 0.1 mg | Office | 11,352 | 38 | $20.86 | $237K |
| Q5126 Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg | Office | 10,570 | 20 | $45.91 | $485K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 3,630 | 76 | $0.09 | $317 |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 1,769 | 23 | $0.23 | $402 |
| J9045 Injection, carboplatin, 50 mg | Office | 1,586 | 50 | $2.74 | $4,341 |
| A9585 Injection, gadobutrol, 0.1 ml | Office | 1,550 | 14 | $0.22 | $344 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 1,200 | 26 | $0.70 | $844 |
| 36415 Venipuncture Blood Collection | Office | 1,118 | 188 | $8.64 | $9,662 |
| 80048 Clinical Chemistry | Office | 1,005 | 140 | $8.28 | $8,325 |
| 85025 Blood Count | Office | 987 | 121 | $7.60 | $7,505 |
By year: 2022 $1.7M for 129,436 services; 2023 $1.6M for 152,244 services; 2024 $2.3M for 176,137 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,118 | 188 | $8.64 | $9,662 |
| 80048 Clinical Chemistry | 1,005 | 140 | $8.28 | $8,325 |
| 85025 Blood Count | 987 | 121 | $7.60 | $7,505 |
| 80076 Clinical Chemistry | 694 | 108 | $8.01 | $5,559 |
| 86304 Immunoassay | 588 | 124 | $20.39 | $12K |
| 84156 Clinical Chemistry | 122 | 21 | $3.60 | $439 |
| 84443 Clinical Chemistry | 49 | 13 | $16.46 | $807 |
| 81015 Clinical Chemistry | 24 | 13 | $2.99 | $71.76 |
| 82728 Clinical Chemistry | 14 | 12 | $13.36 | $187 |
| 83540 Clinical Chemistry | 13 | 11 | $6.34 | $82.42 |
Medicare prescription drug claims, 2024
In 2024, the drug William M Merritt prescribed most often to Medicare patients was Ondansetron Odt (Ondansetron), with 77 prescriptions and refills. In total William M Merritt wrote 688 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ondansetron Odt Ondansetron | 77 | 77 | 42 | $770 |
| Letrozole Generic | 52 | 74 | Under 11 | $564 |
| Tramadol Hcl Generic | 49 | 49 | 46 | $104 |
| Eliquis Apixaban | 47 | 54 | Under 11 | $31K |
| Dexamethasone Generic | 43 | 45 | 30 | $554 |
| Rubraca Rucaparib Camsylate | 36 | 36 | Under 11 | $406K |
| Prochlorperazine Maleate Generic | 30 | 30 | 28 | $228 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 28 | 28 | 15 | $255 |
| Zejula Niraparib Tosylate | 25 | 25 | Under 11 | $444K |
| Potassium Chloride Generic | 25 | 27 | 14 | $314 |
| Oxycodone Hcl Generic | 20 | 20 | 14 | $153 |
| Promethazine Hcl Generic | 18 | 18 | 13 | $95.66 |
| Lenvima Lenvatinib Mesylate | 17 | 17 | Under 11 | $375K |
| Megestrol Acetate Generic | 16 | 20 | Under 11 | $928 |
| Dicyclomine Hcl Generic | 14 | 14 | 14 | $9.68 |
Brand drugs: 146 claims; generic drugs: 542 claims; opioid claims: 127.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid William M Merritt $1,811 ($1,811 in general payments such as food, travel and fees) from 33 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $240.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 12 | $240 |
| Novartis Pharmaceuticals Corporation NVS | 9 | $221 |
| Abbvie Inc. ABBV | 5 | $143 |
| CooperSurgical, Inc. COO | 1 | $107 |
| Pfizer Inc. PFE | 4 | $82.96 |
| Daiichi Sankyo Inc. 4568.T | 3 | $82.66 |
| Janssen Biotech, Inc. JNJ | 4 | $82.25 |
| Jazz Pharmaceuticals Inc. JAZZ | 4 | $65.89 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 2 | $63.51 |
| EMD Serono, Inc. MRK.DE | 3 | $51.62 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.